Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 21551249)

1.

Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.

Mayes DA, Rizvi TA, Cancelas JA, Kolasinski NT, Ciraolo GM, Stemmer-Rachamimov AO, Ratner N.

Cancer Res. 2011 Jul 1;71(13):4675-85. doi: 10.1158/0008-5472.CAN-10-4558. Epub 2011 May 6.

2.

Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.

Le LQ, Liu C, Shipman T, Chen Z, Suter U, Parada LF.

Cancer Res. 2011 Jul 1;71(13):4686-95. doi: 10.1158/0008-5472.CAN-10-4577. Epub 2011 May 6.

3.

The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.

Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A.

Oncogene. 2001 Jan 4;20(1):97-105.

4.

Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.

Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, Rojiani AM, Maria BL, Muir D, Wallace MR.

Genes Chromosomes Cancer. 2000 Aug;28(4):425-31.

PMID:
10862051
5.

Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.

Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, Stemmer-Rachamimov AO, Cancelas JA, Ratner N.

Cancer Cell. 2008 Feb;13(2):105-16. doi: 10.1016/j.ccr.2007.12.027.

6.

Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF.

Science. 2002 May 3;296(5569):920-2.

8.

Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.

Gottfried ON, Viskochil DH, Couldwell WT.

Neurosurg Focus. 2010 Jan;28(1):E8. doi: 10.3171/2009.11.FOCUS09221.

PMID:
20043723
9.

NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.

Kawachi Y, Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Ichikawa E, Furumura M, Otsuka F.

Exp Dermatol. 2013 Apr;22(4):262-5. doi: 10.1111/exd.12115.

PMID:
23528211
10.
11.

Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.

Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E.

Hum Mol Genet. 2000 Apr 12;9(7):1059-66.

12.

Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.

Le LQ, Parada LF.

Oncogene. 2007 Jul 12;26(32):4609-16. Epub 2007 Feb 12. Review.

13.

Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve.

Ribeiro S, Napoli I, White IJ, Parrinello S, Flanagan AM, Suter U, Parada LF, Lloyd AC.

Cell Rep. 2013 Oct 17;5(1):126-36. doi: 10.1016/j.celrep.2013.08.033. Epub 2013 Sep 26.

14.

Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.

Zheng H, Chang L, Patel N, Yang J, Lowe L, Burns DK, Zhu Y.

Cancer Cell. 2008 Feb;13(2):117-28. doi: 10.1016/j.ccr.2008.01.002.

15.

Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.

Däschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, Wortmann S, Heymer B, Kehrer-Sawatzki H.

Biochem Biophys Res Commun. 1997 May 19;234(2):346-50.

PMID:
9177273
16.

Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.

Kluwe L, Friedrich RE, Mautner VF.

Cancer Genet Cytogenet. 1999 Aug;113(1):65-9.

PMID:
10459349
17.

Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma.

Storlazzi CT, Von Steyern FV, Domanski HA, Mandahl N, Mertens F.

Int J Cancer. 2005 Dec 20;117(6):1055-7.

PMID:
15986446
18.

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.

Mußotter T, Kluwe L, Högel J, Nguyen R, Cooper DN, Mautner VF, Kehrer-Sawatzki H.

BMC Med Genet. 2012 Oct 26;13:98. doi: 10.1186/1471-2350-13-98.

19.

PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.

Keng VW, Rahrmann EP, Watson AL, Tschida BR, Moertel CL, Jessen WJ, Rizvi TA, Collins MH, Ratner N, Largaespada DA.

Cancer Res. 2012 Jul 1;72(13):3405-13. doi: 10.1158/0008-5472.CAN-11-4092. Epub 2012 Jun 14.

20.

Mast cells and the neurofibroma microenvironment.

Staser K, Yang FC, Clapp DW.

Blood. 2010 Jul 15;116(2):157-64. doi: 10.1182/blood-2009-09-242875. Epub 2010 Mar 16. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk